الأعمال قيد التحليل بانتظار التحليل الذكي CNBC Business 06 آب 2026, 06:45

The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings

As Lilly widens its lead in the obesity race, Novo is still racing to win back market share and restore investor confidence in its pipeline.

The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings

لماذا يهم هذا الخبر؟

سيظهر الملخص التحليلي هنا بعد اكتمال معالجة الذكاء الاصطناعي.

سياق الخبر

As Lilly widens its lead in the obesity race, Novo is still racing to win back market share and restore investor confidence in its pipeline.

فتح الخبر الأصلي
تغطية مرتبطة

المزيد من أخبار الأعمال